SYMPHOGEN
LIVE

Serial Number

79075883

Owner

Symphogen A/S

Attorney

Maury M. Tepper, III

Filing Date

Oct 2, 2009

Add to watchlist:

No watchlists yet
View on USPTO

SYMPHOGEN Trademark

Serial Number: 79075883 • Registration: 3882672

SYMPHOGEN is a trademark filed by Symphogen A/S on October 2, 2009. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

Symphogen A/S

Pederstrupvej 93

Entity Type: 99

Symphogen AS

Bygning 375,

Entity Type: 99

Trademark Details

Filing Date

October 2, 2009

Registration Date

November 30, 2010

Published for Opposition

September 14, 2010

Goods & Services

Pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of cancer, AIDS (Acquired Immune Deficiency Syndrome) and other infectious diseases, immune and auto-immune diseases, inflammatory diseases and cardiovascular diseases, Idiopathic Thrombocytopenic Purpura (ITP), Hemolytic Disease of Newborns (HDN), smallpox infection and treatment of adverse effects caused by smallpox vaccination and severe respiratory diseases, hematological diseases, and respiratory diseases; veterinary preparations for cancer, AIDS (Acquired Immune Deficiency Syndrome) and other infectious diseases, immune and auto-immune diseases, inflammatory diseases and cardiovascular diseases, smallpox infection and treatment of adverse effects caused by smallpox vaccination and severe respiratory diseases, and hematological diseases; pharmaceutical preparations based on antibodies, including human, animal, monoclonal and polyclonal antibodies for the treatment of cancer, AIDS (Acquired Immune Deficiency Syndrome) and other infectious diseases, immune and auto-immune diseases, inflammatory diseases and cardiovascular diseases, Indiopathic Thrombocytopenic Purpura (ITP), Hemolytic Disease of Newborns (HDN) smallpox infection and treatment of adverse effects caused by smallpox vaccination and severe respiratory diseases, Hematological diseases and respiratory diseases; dietetic foods adapted for medical use

Chemicals used in industry, science and photography; biochemicals, namely, human and animal, monoclonal and polyclonal antibodies for in-vivo or in-vitro scientific research and development, including scientific research into diseases, in particular cancer, AIDS (acquired immune deficiency syndrome) and other infectious diseases, immune and auto-immune diseases, inflammatory diseases and cardiovascular diseases

[ Patent licensing; Patent and industrial property consultation; licensing of industrial property within medical science ]

Research in the field of medical science, including biological research and in particular research into antibodies, including human, animal, monoclonal and polyclonal antibodies and the development of medicines based on antibodies, including human, animal, monoclonal and polyclonal antibodies; chemical analyses; [ computer programming, namely, computer programming for the gathering and processing of medical data in connection with medical science research, development and therapy, including research into, development of, and therapy using antibodies, including human, animal, monoclonal and polyclonal antibodies ]

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jun 20, 2022 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jun 11, 2022 NREP
PARTIAL INVALIDATION PROCESSED BY THE IB
Apr 23, 2022 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 12, 2022 INPS
INVALIDATION PROCESSED
Mar 12, 2022 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 2, 2021 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Mar 2, 2021 NA71
REGISTERED-SEC.71 ACCEPTED
Mar 2, 2021 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 2, 2021 APRE
TEAS SECTION 71 RECEIVED
Nov 16, 2020 ES71
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 30, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 30, 2020 TCCA
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Oct 30, 2020 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 30, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 30, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 30, 2020 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Apr 23, 2020 NREP
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Nov 30, 2019 REM4
INTERNATIONAL REGISTRATION RENEWED
Oct 17, 2019 RNWL
NEW REPRESENTATIVE AT IB RECEIVED
Aug 8, 2019 NREP
PARTIAL INVALIDATION PROCESSED BY THE IB
Jan 11, 2018 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Dec 1, 2017 INPS
INVALIDATION PROCESSED
Dec 1, 2017 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 15, 2017 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Mar 15, 2017 NA75
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Mar 15, 2017 C75P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 15, 2017 APRE
CHANGE OF NAME/ADDRESS REC'D FROM IB
Mar 9, 2017 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Mar 2, 2017 NREP
TEAS SECTION 71 & 15 RECEIVED
Oct 3, 2016 ES75
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 18, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 31, 2011 FICS
FINAL DISPOSITION PROCESSED
Mar 31, 2011 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 28, 2011 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 30, 2010 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2010 NPUB
PUBLISHED FOR OPPOSITION
Sep 14, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 12, 2010 PREV
ASSIGNED TO LIE
Aug 12, 2010 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 27, 2010 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 27, 2010 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 27, 2010 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 27, 2010 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 27, 2010 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 1, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 1, 2010 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 30, 2010 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 30, 2010 REAP
REFUSAL PROCESSED BY IB
Jan 29, 2010 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 5, 2010 RFCS
REFUSAL PROCESSED BY MPU
Jan 5, 2010 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 2, 2010 RFCR
NON-FINAL ACTION WRITTEN
Jan 1, 2010 CNRT
ASSIGNED TO EXAMINER
Dec 30, 2009 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 26, 2009 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 22, 2009 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 17, 2009 REPR